Panel Discussion & Q&A: The Role of Liquid Biopsy in Enabling Development of Biomarker-driven Targeted Therapies

Time: 6:35 pm
day: Agilent Engager


  • Evolving landscape of biomarker testing across tumour types
  • Discovering actionable mechanisms of resistance in liquid biopsy
  • Leveraging continued advances in liquid biopsy’s accessibility and accuracy to advance novel biomarker discovery